🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are urged to message these profiles directly for source information, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Vendors market the substance there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in individuals administering products of uncertain source.

Some experts said the demand for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Service Response and Content Elimination

Based on TikTok, the platform has removed violative material and banned related hashtags and query recommendations. The company said it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found communities with up to nine thousand participants selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, filled with photos of weight loss, positive testimonials and detailed instructions for preparing or injecting at home.

Within minutes of entering one group, a vendor shared contact information, where most transactions take place. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Item Details and Costs

Within these communities, posts display black plastic parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for the messaging service said it regularly moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they cannot confirm. Even if the science behind retatrutide is valid, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to possibly significant medical dangers”.